CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

Abstract: Existing CPU scaling approaches have limitations that can lead to inefficient resource allocation and increased penalty costs for tasks with soft deadlines running in container clouds. First ...

Researchers have developed a way to program human cells to perform calculations and make autonomous decisions, similar to how ...

OpenAI Group PBC today introduced GPT-5.6, a new series of large language models that it says can outperform Claude Mythos 5 ...